PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on WednesdayThursday, October 26–27. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Psychiatry

 

What happens when your patient does not respond to treatment with an SSRI? This session will review how to manage challenging cases of depression that are all too common in a primary care setting.

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL

9:10–10:10am ET    CME/CE Accredited Session

Diabetes

Employing Innovation and Overcoming Inertia: New Options in Basal Insulin  

Michelle F. Magee, MD, MBBCh, BAO, LRCPSI | Jay H. Shubrook, DO, FAAFP, FACOFP

 

Are you comfortable distinguishing among traditional and newer basal insulins and selecting appropriate therapy for patients with diabetes? This 60-minute session delivers a deep dive into the differences among available insulin agents and helps you optimize treatment and reduce the risk of hypoglycemia. Expert faculty will guide you through a patient case that illustrates how to employ a patient-centered approach to insulin therapy with a strong focus on effective patient-clinician communication. You’ll walk away with guideline-concordant strategies to alleviate patient fears and hesitancies toward insulin and avoid costly therapeutic inertia.

Michelle F. Magee, MD, MBBCh, BAO, LRCPSI

Director, MedStar Health Diabetes Institute, Professor of Medicine, Georgetown University School of Medicine, Washington, DC

Jay H. Shubrook, DO, FAAFP, FACOFP

Professor, Primary Care Department, Director, Diabetes Services, Touro University College of Osteopathic Medicine, Vallejo, CA

Supported by Novo Nordisk Inc.

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

A Clinician’s Perspective on Managing Patients with Asthma

Ron Balkissoon, MD

 

Asthma is a significant public health concern in the US, making its diagnosis and management in clinical practice critically important, especially with recent increasing trends in prevalence and morbidity. With the help of engaging case-studies, this session will include discussions on the identification, diagnostic workup, and effective management of asthma. It will also review the assessment of symptom control and severity in patients with asthma

Ron Balkissoon, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

10:20–11:05am ET    Non-CME Industry Theater

Gastroenterology

Donna Cryer | Kenneth Cusi, MD, FACP, FACE

 

Nonalcoholic fatty liver disease (NAFLD) often occurs in patients with obesity, type 2 diabetes (T2D), insulin resistance, and atherogenic dyslipidemia and is the manifestation of metabolic disease in the liver. It is estimated that over 80 million people in the United States (US) are living with NAFLD and that 20% of NAFLD patients in the US have nonalcoholic steatohepatitis (NASH), the more severe and progressive stage of NAFLD.

Join us in sharing the American Association of Clinical Endocrinology (AACE) new clinical practice guidelines and recommendations for the diagnosis and management of NAFLD. 

Donna Cryer

Kenneth Cusi, MD, FACP, FACE

Sponsored by Labcorp

11:15am–12:15pm ET    CME/CE Accredited Session

Cardiovascular Medicine

 

Cardiovascular Genetics provides a mechanism for precision medicine. In this one-hour session, learn about the core concepts of Cardiovascular Genetics, patient selection for genetic testing, the importance of genetic counseling, and how results might change management. This session combines didactics and case-based learning to provide practical approaches for your patients with heritable cardiovascular conditions.

Lisa D. Wilsbacher, MD, PhD

Associate Professor, Northwestern University, Feinberg School of Medicine, Chicago, IL

12:25–1:25pm ET    CME/CE Accredited Session

Complementary & Alternative Medicine

 

Get updated on the latest scientific and clinical evidence about how cannabis impacts the body, brain and mind.   This presentation will describe which medical conditions cannabis can treat and the short term and long term effects of cannabis use.   Cases and discussion will help to inform clinicians on what to say to patients inquiring about cannabis use.

Timothy Fong, MD

Professor of Psychiatry, Co-Director, UCLA Gambling Studies Program, Director, UCLA Addiction Psychiatry Fellowship, David Geffen School of Medicine at UCLA, Los Angeles, CA

1:35–2:20pm ET    Non-CME Industry Theater

Urology

DISCOVER THE IMPACT OF GEMTESA: A Selective B3-Adrenergic Agonist for Effective OAB Treatment

Matt T Rosenberg, MD

 

Matt T Rosenberg, MD

Sponsored by Sunovion Pharmaceuticals Inc.

1:35–2:20pm ET    Non-CME Industry Theater

Endocrinology

Ted Okerson, MD, FACP, FACE

 

  • Recognize the health burden and prevalence of both CKD and hyperkalemia
  • Review screening and monitoring recommendations for patients with CKD
  • Understand CKD and hyperkalemia risk factors
  • Highlight current approaches to the management of CKD and hyperkalemia 

Ted Okerson, MD, FACP, FACE

Sponsored by AstraZeneca Pharmaceuticals, LP

2:30–3:30pm ET    CME/CE Accredited Session

Infectious Diseases

COVID-19 Cases in Primary Care 

Laila Woc-Colburn, MD

 

COVID-19 has driven many decisions in healthcare since early 2020. Vaccination is effective in reduction in disease severity and prevention. This session will give providers tools and strategies to effectively implement outpatient antiviral treatment to minimize the impact of COVID on their high-risk patients.

Laila Woc-Colburn, MD

Associate Professor, Division of Infectious Diseases Emory University School of Medicine, Atlanta, GA

3:40–4:40pm ET    CME/CE Accredited Session

Hot Topics

 

Staying current with medications across the breadth and depth of primary care is daunting. This presentation will provide a concise review of four specific classes of drugs commonly seen in primary care -- or specifically requested by patients -- based upon the application of the most current evidence and guidelines currently available. 

Lawrence Herman, DMSc, MPA, PA-C, DFAAPA

Adjunct Professor, Doctor of Medical Science Program, University of Lynchburg, Lynchburg, Virginia, President, Palantir Healthcare, LLC, Boiling Springs, South Carolina

4:50–5:35pm ET    Non-CME Industry Theater

Pulmonology

Understanding Chronic Cough: Patient Presentation and Assessment

Kenneth W. Altman, MD, PhD

 

Kenneth W. Altman, MD, PhD

Sponsored by Merck

8–9am ET    CME/CE Accredited Session

Ophthalmology

Common Acute Eye Problems 

Yvonne I. Chu, MD, MBA

 

This 45-minute session will answer some frequently asked questions by attendee at prior Pri-Med conferences, and help the primary care provider brush up on common acute eye complaints and when to consider urgently referring the patient to an eye care specialist.

Yvonne I. Chu, MD, MBA

Associate Professor,, Department of Opthhalmology,, Cullen Eye Institute,, Baylor College of Medicine,, Houston, TX

9:10–10:10am ET    CME/CE Accredited Session

Infectious Disease

Diagnosis and Management of Influenza

Charles Vega, MD, FAAFP | Robert H. Hopkins, Jr., MD, MACP, FAAP

 

With influenza season here, arm yourself with the latest guideline-recommended strategies for diagnosing, treating, and preventing this potentially serious illness. Through a series of patient vignettes, you will gain confidence in appropriately identifying patients—especially high-risk patients—for treatment and post-exposure prophylaxis, and you will review which therapies are FDA approved for each purpose. Join us for this can’t-miss session to mitigate the burden of influenza this season.

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA

Robert H. Hopkins, Jr., MD, MACP, FAAP

Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR

Supported by an educational grant from Genentech, a member of the Roche Group.

10:20–11:05am ET    Non-CME Industry Theater

Gastroenterology

Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

 

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.

Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

Gastroenterologist, University of Texas Health Science Center at Houston

Sponsored by AbbVie

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

Preventing COPD Exacerbations: The Need for Proactive, Optimized Management of COPD

Neil Skolnik, MD

 

Uncovering the burden of COPD exacerbations may help in generating an appreciation of the range of potential consequences to the patient. In this program, learn about defining exacerbation severity in COPD, possible impacts of moderate and severe COPD exacerbations, and important considerations for appropriate COPD management.

Neil Skolnik, MD

Neil Skolnik, MD

Sponsored by AstraZeneca Pharmaceuticals, LP

11:15am–12:15pm ET    CME/CE Accredited Session

Endocrinology

The Renaissance of SGLT2 Inhibitors—Not Just for Diabetes Anymore

Charles Vega, MD, FAAFP | Christopher Cannon, MD

 

SGLT2 inhibitors are no longer indicated as treatment solely for diabetes and are becoming the standard of care in heart failure and chronic kidney disease as well. This 60-minute session will address SGLT2 inhibitor use in diabetes as well as present updated indications for use in heart failure and chronic kidney disease, regardless of diabetes status. Through didactic and case-based education, learners will gain confidence in applying the most recent guidelines for SGLT2 inhibitor use to ensure optimal outcomes for their patients. 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA

Christopher Cannon, MD

Cardiovascular Division, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Supported by Merck & Co., Inc.

12:25–1:25pm ET    CME/CE Accredited Session

Neurology

Neurology Pearls 

Katherine Carroll, MD

 

Neurology Pearls will provide the primary care clinician with the most up-to-date knowledge needed to identify and treat commonly seen neurological outpatient diagnoses, including headache, dizziness, peripheral neuropathy, tremor, and seizure vs. syncope.

Katherine Carroll, MD

Assistant Professor of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL

1:35–2:20pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO

 

  • Understand the causes and prevalence of chronic low back pain
  • Differentiate inflammatory back pain (IBP) from mechanical back pain
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner

Christopher Parker, DO

Sponsored by AbbVie

1:35–2:20pm ET    Non-CME Industry Theater

Stroke

Ted Okerson, MD, FACP, FACE

 

  • Understand the risk factors that contribute to the elevated risk for thrombotic cardiovascular events pre- and post-myocardial infarction in patients across the coronary artery disease spectrum.
  • Differentiate oral P2Y12 inhibitors with respect to their clinical pharmacology and examine the select differences between oral and antiplatelet therapies.
  • Describe the role of BRILINTA in reducing the risk of cardiovascular events in patients with acute coronary syndrome, history of myocardial infarction, and high-risk coronary artery disease without prior myocardial infarction.

Ted Okerson, MD, FACP, FACE

Sponsored by AstraZeneca Pharmaceuticals, LP

2:30–3:30pm ET    CME/CE Accredited Session

Hot Topics

 

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

3:40–4:40pm ET    CME/CE Accredited Session

Wellness

 

What should I eat? This is a top question primary care providers are often asked to address. An explosion of evidence based and popular approaches to addressing chronic illness have complicated this answer. Primary care providers are asked to juggle media trends, science and feasibility when prescribing nutrition therapies. We will address the science and behavioral tricks behind elimination diets, Keto diets and fasting.

Bethany Doerfler, MS, RDN

Clinical Research Dietitian, Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL

4:50–5:35pm ET    Non-CME Industry Theater

Hematology

Changing the Cancer Landscape with Multi-Cancer Early Detection (MCED) Screening  

Mylynda B. Massart, MD, PhD | Candace Westgate, DO | Sana Raoof, MD, PhD

 

Recommended screening tests exist for only a few cancers. The Galleri multi-cancer early detection test screens for multiple cancers through a simple blood draw. Adding Galleri to standard-of-care cancer screening provides an opportunity to detect many more cancers. Join us to learn how physicians are using the Galleri test in their practices and its impact on their patients.

Mylynda B. Massart, MD, PhD

MD, PhD, Founder/Director, UPMC, Primary Care Precision Medicine Center, Chair of Family Medicine Co-director for the HUB Core

Candace Westgate, DO

DO, Medical Director of Women and Infant Services and Adventist Health Founder, AHEAD Program

Sana Raoof, MD, PhD

Physician Scientist, Memorial Sloan Kettering

Sponsored by GRAIL, LLC